Back to Stakeholders
One of the largest private philanthropic funders of psychedelic research, having committed over $60 million to the field. The Foundation's Psychedelic Research & Health Initiative supports MDMA-assisted therapy trials for veteran PTSD through MAPS, psilocybin research at Mount Sinai, and patient-assistance programs to ensure equitable access if therapies receive FDA approval.
Quick Facts
- Type
- Non-Profit
- HQ
- United States
- Website
- Visit